'Signposts on the journey'; medication adherence and the lived body in men with Parkinson's disease

被引:13
|
作者
Gibson, Grant [1 ]
机构
[1] Univ Stirling, Sch Appl Social Sci, Colin Bell Bldg, Stirling FK9 4LA, Scotland
关键词
UK; Parkinson's disease; Lived body; Embodiment; Medication; Adherence; OLDER-ADULTS; EXPERIENCE; MEDICINE;
D O I
10.1016/j.socscimed.2016.01.023
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Adherence to medication has been identified as a key issue in the treatment of many chronic illnesses, however such a perspective fails to account for the lived experience of medication usage and its effects on the body as lived. Parkinson's Disease, a neurological disease predominantly affecting movement and mobility, and which is treated via a wide range of medications provides a useful opportunity to explore experiences of medication usage in chronic illness. Reporting on findings of a study exploring men's experience of living with Parkinson's Disease, this paper adopts a lived body perspective to explore lived experiences of medication usage and adherence in PD. Findings are reported from 30 narrative in depth interviews with 15 men of various ages living with Parkinson's disease of mild to severe intensity. Findings first discuss PD's effects on men's sense of the lived body, in which a fluctuating embodiment is linked to medication regimes and their bodily effects. Second, as PD disrupts the body's place with the everyday and habitual experience of lived time, medication regimens come to place new structures upon the men's everyday experience of time. Finally, the paper explores the role medications play in men's attempts to create and sustain narratives for the individual progression of their illness, and how these narratives differ from clinical narratives associated with PD's treatment. This paper concludes by discussing debates around adherence to medication within the treatment of PD and the need to consider lived experience of medication usage and their effects at the level of the lived body. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 50 条
  • [1] Challenges and strategies of medication adherence in Parkinson's disease: A qualitative study
    Shin, Ju Young
    Habermann, Barbara
    Pretzer-Aboff, Ingrid
    GERIATRIC NURSING, 2015, 36 (03) : 192 - 196
  • [2] Suboptimal medication adherence in Parkinson's disease
    Grosset, KA
    Bone, I
    Grosset, DG
    MOVEMENT DISORDERS, 2005, 20 (11) : 1502 - 1507
  • [3] Medication Adherence in Patients with Parkinson's Disease
    Malek, Naveed
    Grosset, Donald G.
    CNS DRUGS, 2015, 29 (01) : 47 - 53
  • [4] Systematic review on factors associated with medication non-adherence in Parkinson's disease
    Daley, David James
    Myint, Phyo Kyaw
    Gray, Richard John
    Deane, Katherine Helen O'Leary
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (10) : 1053 - 1061
  • [5] Lived experience of domestic violence among men with Parkinson?s disease: A qualitative study
    Bayen, Sabine
    Talbi, Sabrina
    Cauet, Charles
    Joomun, Fawaz
    Cottencin, Olivier
    Moreau, Caroline
    Defebvre, Luc
    Devos, David
    Messaadi, Nassir
    PATIENT EDUCATION AND COUNSELING, 2022, 105 (11) : 3306 - 3312
  • [6] Effect of medication non-adherence on Parkinson's disease psychosis
    Gabr, Wael
    El-Azouni, Osama
    MEDICAL SCIENCE, 2020, 24 (104) : 1828 - 1838
  • [7] Medication Nonadherence in Parkinson’s Disease
    Jori E. Fleisher
    Matthew B. Stern
    Current Neurology and Neuroscience Reports, 2013, 13
  • [8] Medication Nonadherence in Parkinson's Disease
    Fleisher, Jori E.
    Stern, Matthew B.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (10)
  • [9] Drug adherence in Parkinson's disease
    Leopold, NA
    Polansky, M
    Hurka, MR
    MOVEMENT DISORDERS, 2004, 19 (05) : 513 - 517
  • [10] Using the theoretical domains framework to determine the barriers and facilitators to medication adherence in Parkinson's disease
    Smith, J. C.
    Seage, C. H.
    Lane, E.
    James, D. H.
    EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2023, 11